The addition of targeted therapy helps control metastatic breast cancer, and a pair of immunotherapy drugs prolongs survival in multiple myeloma.

by Thomas Celona

Research continues to show efficacy of HPV vaccines at preventing cervical cancer, and the FDA approves an immunotherapy for use before and after surgery for stomach cancers.

by Eric Fitzsimmons

80% of eligible Americans do not get annual lung cancer screenings, and breast cancer risk varies by type of hormonal birth control used.

by Darlene Dobkowski

Many doctors don’t prescribe hormone therapy in women with gynecologic cancers, and cancer-related crowdfunding often falls short of goals.

by Marci Landsmann

More people with breast cancer can forgo radiation after surgery, and a treatment combination helps control esophageal cancer.

by Thomas Celona

People with history of polyps often do not get follow-up colonoscopy after a positive FIT test, and early-onset cancers are rising in Corn Belt states.

by Eric Fitzsimmons

COVID vaccines may improve immunotherapy effects, and a drug combination reduces the risk for death in bladder cancer.

by Darlene Dobkowski

Prior authorizations pose a significant time burden for patients, and sentinel lymph node biopsy reduces side effects in cervical cancer.

by Marci A. Landsmann

Older people with multiple myeloma can receive a less toxic drug regimen, and the FDA approves an immunotherapy for people with high-risk skin cancer.

by Thomas Celona

Widespread uptake of HPV vaccine linked to reduced rates of cancer-causing infection in all, and radiation prevents recurrence in locally advanced bladder cancer.

by Eric Fitzsimmons